Pharma-Bio Serv (OTCMKTS:PBSV) Issues Earnings Results, Misses Estimates By $0.04 EPS

Pharma-Bio Serv (OTCMKTS:PBSV) posted its earnings results on Monday. The company reported ($0.01) EPS for the quarter, missing the consensus estimate of $0.03 by ($0.04), Yahoo Finance reports. Pharma-Bio Serv had a negative return on equity of 0.04% and a negative net margin of 0.05%. The business had revenue of $2.42 million for the quarter, compared to analyst estimates of $3.50 million.

Pharma-Bio Serv Price Performance

Shares of Pharma-Bio Serv stock opened at $0.63 on Wednesday. Pharma-Bio Serv has a twelve month low of $0.52 and a twelve month high of $1.09. The company’s fifty day moving average is $0.62 and its 200 day moving average is $0.69.

About Pharma-Bio Serv

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.